InvestorsHub Logo
Followers 0
Posts 26
Boards Moderated 0
Alias Born 02/08/2007

Re: None

Tuesday, 03/12/2019 6:52:18 AM

Tuesday, March 12, 2019 6:52:18 AM

Post# of 16696
http://www.nashbiotechs.com/nash-biotech-analysis/biotechs-targeting-nash/detailledList.php

NP160 (NP160), Laboratory : NashPharmaceuticals
Type of drug : ??

Clinical trials advancement : Preclinic

The drug got the Fast Track Status granted by the FDA and is eligible for Subpart H on intermediate results of Phase 3

Estimated Time to market in months : 105



NP135 (NP135), Laboratory : NashPharmaceuticals
Type of drug : ??

Clinical trials advancement : Preclinic

The drug got the Fast Track Status granted by the FDA and is eligible for Subpart H on intermediate results of Phase 3

Estimated Time to market in months : 106